ArticleJournal for immunotherapy of cancer2023

TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment.

Miso Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.